Paper30282950
Regional Absorption of Fimasartan in the Gastrointestinal Tract by an Improved in situ Absorption Method in Rats.
Kim TH and 10 others. Pharmaceutics, 2018. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Regional Absorption of Fimasartan in the Gastrointestinal Tract by an Improved in situ Absorption Method in Rats. Papers, record 30282950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30282950
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Regional Absorption of Fimasartan in the Gastrointestinal Tract by an Improved in situ Absorption Method in Rats.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2018R1A2B6004928 | National Research Foundation of Korea | PubMed | ||
| 16173MFDS542 in 2018 | Ministry of Food and Drug Safety | PubMed |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11274897 | Current methodologies used for evaluation of intestinal permeability and absorption. | J Pharmacol Toxicol Methods | 2000 | https://conductscience.org/library/papers/11274897 | PubMed |
| 2 | 11480535 | Evaluation of a single-pass intestinal-perfusion method in rat for the prediction of absorption in man. | J Pharm Pharmacol | 2001 | https://conductscience.org/library/papers/11480535 | PubMed |
| 4 | 1366578 | Solid phase membrane mimetics: immobilized artificial membranes. | Enzyme Microb Technol | 1990 | https://conductscience.org/library/papers/1366578 | PubMed |
| 6 | 17727800 | Predicting human intestinal permeability using single-pass intestinal perfusion in rat. | J Pharm Pharm Sci | 2007 | https://conductscience.org/library/papers/17727800 | PubMed |
| 7 | 21268050 | Simultaneous determination of fimasartan, a novel antihypertensive agent, and its active metabolite in rat plasma by liquid chromatography-tandem mass spectrometry. | Biomed Chromatogr | 2011 | https://conductscience.org/library/papers/21268050 | PubMed |
| 8 | 22264484 | Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists. | Bioorg Med Chem Lett | 2012 | https://conductscience.org/library/papers/22264484 | PubMed |
| 9 | 22381711 | Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension. | Clin Ther | 2012 | https://conductscience.org/library/papers/22381711 | PubMed |
| 10 | 23811571 | Pharmacological characterization of BR-A-657, a highly potent nonpeptide angiotensin II receptor antagonist. | Biol Pharm Bull | 2013 | https://conductscience.org/library/papers/23811571 | PubMed |
| 11 | 24206063 | Human in vivo regional intestinal permeability: importance for pharmaceutical drug development. | Mol Pharm | 2014 | https://conductscience.org/library/papers/24206063 | PubMed |
| 12 | 24644298 | Quantitative determination of absorption and first-pass metabolism of apicidin, a potent histone deacetylase inhibitor. | Drug Metab Dispos | 2014 | https://conductscience.org/library/papers/24644298 | PubMed |
| 13 | 2470075 | The Madin Darby canine kidney (MDCK) epithelial cell monolayer as a model cellular transport barrier. | Pharm Res | 1989 | https://conductscience.org/library/papers/2470075 | PubMed |
| 14 | 24786684 | Pharmacokinetics and metabolite profiling of fimasartan, a novel antihypertensive agent, in rats. | Xenobiotica | 2014 | https://conductscience.org/library/papers/24786684 | PubMed |
| 15 | 25990964 | Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans. | AAPS J | 2015 | https://conductscience.org/library/papers/25990964 | PubMed |
| 16 | 26272450 | Absolute bioavailability and pharmacokinetics of the angiotensin II receptor antagonist fimasartan in healthy subjects. | J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26272450 | PubMed |
| 17 | 26895020 | Predicting Drug Extraction in the Human Gut Wall: Assessing Contributions from Drug Metabolizing Enzymes and Transporter Proteins using Preclinical Models. | Clin Pharmacokinet | 2016 | https://conductscience.org/library/papers/26895020 | PubMed |
| 18 | 27768097 | Materials and methods for delivery of biological drugs. | Nat Chem | 2016 | https://conductscience.org/library/papers/27768097 | PubMed |
| 19 | 28920690 | Regional Intestinal Permeability in Rats: A Comparison of Methods. | Mol Pharm | 2017 | https://conductscience.org/library/papers/28920690 | PubMed |
| 20 | 4692832 | Glucose transport in isolated brush border membrane from rat small intestine. | J Biol Chem | 1973 | https://conductscience.org/library/papers/4692832 | PubMed |
| 21 | 7266016 | Predicted absorption rates with simultaneous bulk fluid flow in the intestinal tract. | J Theor Biol | 1981 | https://conductscience.org/library/papers/7266016 | PubMed |
| 22 | 8527686 | Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. | Biopharm Drug Dispos | 1995 | https://conductscience.org/library/papers/8527686 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33440126 | Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants. | Expert Rev Proteomics | 2020 | https://conductscience.org/library/papers/33440126 | PubMed |
| 33050089 | Hyaluronic Acid in the Intestinal Tract: Influence of Structure, Rheology, and Mucoadhesion on the Intestinal Uptake in Rats. | Biomolecules | 2020 | https://conductscience.org/library/papers/33050089 | PubMed |
| 31938935 | Development of a Population Pharmacokinetics-Based in vitro-in vivo Correlation Model for Drugs with Site-Dependent Absorption: the Acyclovir Case Study. | AAPS J | 2020 | https://conductscience.org/library/papers/31938935 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30282950
GET https://conductscience.org/api/papers/v1/30282950/references?page=2